WFH news
-
Global dosing hold in fitusiran trials initiated by Sanofi Genzyme to investigate new adverse events
A joint statement of the World Federation of Hemophilia (WFH), European Haemophilia Consortium (EHC) and National Hemophilia Foundation (NHF) November 6, 2020 – The WFH,...
-
Report on the Annual Global Survey 2019 now available
The Report on the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) 2019 is now available online. The report includes global demographic and treatment-related...
-
Cesar Garrido, the new President of the WFH, discusses goals and challenges
Cesar Garrido was elected as President of the World Federation of Hemophilia (WFH) at the 2020 Annual Meeting of the General Assembly held virtually on...
-
Enrollment in gene therapy trials on hold for assessment of interim data: Takeda
Takeda has suspended screening and further enrollment in the clinical studies of its AAV8 gene therapies for the treatment of hemophilia A and B. The...
-
Latifa Lamhene and Baiba Ziemele co-opted to WFH Board of Directors
The World Federation of Hemophilia (WFH) 2020 Annual Meeting of the General Assembly was held on October 16, and saw the election of a new...
